glp 1 shortage GLP-1 Antagonists Increase Plan Drug Spend - What's Next GLP-1s Going Direct, How Novo

In late April, the Food and Drug Administration resolved the Wegovy shortage based on its conclusion that Novo Nordisk is fully meeting current and projected nationwide demand for this medicine

Retatrutide NAFLD - Phase 2 Trial Results in Subset of Patients with Obesity and NAFLD

Comparison with previous studies The SUSTAIN 9 (Semaglutide once weekly as add-on to SGLT-2i therapy in T2DM) and SURPASS-1 (Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist Tirzepatide in patients with type 2 diabetes) trials demonstrated that both SGLT2i and GLP-1RAs reduced HbA1c and body weight levels compared with placebo in patients with a history of medical treatment for diabetes ( Safety outcomes The SUSTAIN-9 trial demonstrated an association between SGLT2i use and genital and urinary tract infections ( Discrepancies in the SGLT2i or GLP-1RA type and dosage across studies may have influenced the results

What Is GLP-1 GLP-1, or glucagon-like peptide-1, is a hormone released in the gut after eating